ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 2, 2002, Pages 439-444

  Westfall, David P ^a   Todorov, Latchezar D ^a   Mihaylova Todorova, Svetlana T ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE KINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; ENZYME; HYDROLASE; NEUROTRANSMITTER; NORADRENALIN; NUCLEOTIDASE;

ARTICLE; CELL MEMBRANE; GUINEA PIG; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RODENT; SYMPATHETIC NERVE; SYNAPSE VESICLE; VAS DEFERENS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ENZYMES; HUMANS; NEUROTRANSMITTER AGENTS; NUCLEOTIDASES; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 0036827582     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.035113     Document Type: Article

References (60)

1. Abbracchio MP and Burnstock G (1998) Purinergic signaling: Pathophysiological roles. Jpn J Pharmacol 78:113-145.
2. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 16:73-93.
3. Bitran M, Torres G, Fournier A, St. Pierre S, and Huidobro-Toro JP (1991) Age and castration modulate the inhibitory action of neuropeptide Y on neurotransmission in the rat vas deferens. Eur J Pharmacol 203:267-274.
4. Brock JA, Bridgewater M, and Cunnane TC (1997) Beta-adrenocepter mediated facilitation of noradrenaline and adenosine 5′-triphosphate release from sympathetic nerves supplying the rat-tail artery. Br J Pharmacol 120:769-776.
5. 2+ channel blockers on noradrenaline release and purinergic neuroeffector transmission in rat-tail artery. Br J Pharmacol 126:11-18.
6. Brock JA, Dunn WR, Boyd NS, and Wong KY (2000) Spontaneous release of large packets of noradrenaline from sympathetic nerve terminals in the rat mesenteric artery in vitro. Br J Pharmacol 131:1507-1511.
7. Brown DA, Docherty JR, French AM, MacDonald A, McGrath JR, and Scott NC (1983) Separation of adrenergic and non-cholinergic contractions to field stimulation in the rat vas deferens. Br J Pharmacol 79:379-393.
8. Bultmann R, Wittenburg H, Pause B, Kurz G, Nickel P, and Starke K (1996) P2-purinoceptor antagonists III blockade of P2-purinoceptor subtypes and ectonucleotidases by compounds related to suramin. Naunyn-Schmiedeberg's Arch Pharmacol 354:498-504.
9. Burnstock G (1999) Purinergic cotransmission. Brain Research Bulletin 50:355-357.
10. Burnstock G and Williams M (2000) P2 purinergic receptors: Modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295:862-869.
11. Crack BE, Pollard CE, Beukers MW, Roberts SM, Hunt SF, Ingall AH, McKechnie KC, Ijzerman AP, and Leff P (1995) Pharmacological and biochemical analysis of FPL 67156 a novel selective inhibitor of ecto-ATPase. Br J Pharmacol 114:475-481.
12. Driessen B, von Kugelgen I, and Starke K (1993) Neural ATP release and its a2-adrenoceptor-mediated modulation in guinea-pig vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348:358-366.
13. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, et al. (1999) Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010-1017.
14. Fedan JS, Hogaboom GK, O'Donnell JP, Colby J, and Westfall DP (1981) Contribution of purines to the neurogenic response of the vas deferens of the guinea pig. Eur J Pharmacol 69:41-53.
15. Forsyth KM, Bjur RA, and Westfall DP (1991) Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens. J Pharmacol Exp Ther 256:821-826.
16. Furness JB, Morris JL, Gibbins IL, and Costa M (1989) Chem coding of neurons and plurichemical transmission. Annu Rev Pharmacol Toxicol 29:289-306.
17. Gayle RB III, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JH, Islam N, et al. (1998) Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 101:1851-1859.
18. Gordon JL (1986) Extracellular ATP: Effects, sources and fate. Biochem J 233:309-319.
19. Hedqvist P and Fredholm BB (1976) Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn-Schmiedeberg's Arch Pharmacol 293:217-223.
20. Hokfelt T, Bean A, Ceccatelli S, Dagerlind A, Elde RP, Goldstein M, Meister B, Melander T, Nicholas AP, and Pelto-Huikko M (1992) Neuropeptides and classical transmitters. Localization and interaction. Arzneimittelforschung 42:196-201.
21. Hooper NM (1997) Glycosyl-phosphatidylinositol anchored membrane enzymes. Clin Chim Acta 266:3-12.
22. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, and Robson SC (1996) Identifcation and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem 271:33116-33122.
23. Kasakov L, Ellis J, Kirkpatrick K, Milner P, and Burnstock G (1988) Direct evidence for concomitant release of noradrenaline, adenosine 5′-triphosphate and neuropeptide Y from sympathetic nerves supplying the guinea-pig vas deferens. J Auton Nerv Syst 22:75-82.
24. Khoyi MA, Westfall DP, Buxton ILO, Akhtar-Khavari F, Rezaei E, Salakes M, and Sanchez-Garcia P (1988) Norepinephrine and potassium induced calcium translocation in rat vas deferens. J Pharmacol Exp Ther 246:917-923.
25. Kirkpatrick KA and Burnstock G (1992) Evidence that the inhibition of ATP release from sympathetic nerves by adenosine is a physiological mechanism. Gen Pharmacol 23:1045-1050.
26. Imai M, Takigami K, Guckelberger O, Enjyoji K, Smith RN, Lin Y, Csizmadia E, Sevigny J, Rosenberg RD, Bach FH, and Robson SC (1999) Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)CD39 in xenograft rejection. Mol Med 5:743-52.
27. Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects of amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48:113-178.
28. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, et al. (1997) The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99:1351-1360.
29. Marti E, Canti C, Gomez de Aranda I, Miralles F, and Solsona C (1996) Action of suramin upon ecto-apyrase activity and synaptic depression of Torpedo electric organ. Br J Pharmacol 118:1232-1236.
30. Mihaylova-Todorova S, Todorov LD, and Westfall DP (2001) Correlation between the release of the sympathetic neurotransmitter ATP and soluble nucleotidases from the guinea pig vas deferens. J Pharmacol Exp Ther 296:64-70.
31. Mihaylova-Todorova S, Todorov LD, and Westfall DP (2002) Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated vas deferens during nerve stimulation. Evidence for a soluble ectonucleoside triphosphate diphosphohydrolase-like ATPase and a soluble ecto-5′-nucleotidase-like AMPase. J Pharmacol Exp Ther 302:992-1001.
32. Paton DM (1981) Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: Evidence for action on A1 receptors. J Auton Pharmacol 1:287-290.
33. Pearson JD, Coade SB, and Cusack NJ (1985) Characterization of ectonucleotidases on vascular smooth-muscle cells. Biochem J 230:503-507.
34. Plesner L (1995) Ecto-ATPases identities and functions. Int Rev Cytol 158:141-214.
35. Shinozuka K, Bjur RA, and Westfall DP (1988) Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery. Naunyn-Schmiedeberg's Arch Pharmacol 338:221-227.
36. Silinsky EM, von Kügelgen I, Smith A, and Westfall DP (1998) Functions of extracellular nucleotides in peripheral and central neuronal tissues, in The P2 Nucleotide Receptors (Turner JT, Weisman GA, and Fedan JS eds) pp 259-290, Humana Press, Inc., Totowa.
37. Sneddon P and Westfall DP (1984) Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol 347:561-580.
38. Sneddon P, Westfall DP, and Fedan JS (1982) Cotransmitters in the motor nerves of the guinea pig vas deferens: Electrophysiological evidence. Science (Wash DC) 218:693-695.
39. Stjarne L (1989) Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic varicosities. Rev Physiol Biochem Pharmacol 112:1-137.
40. Stjarne L (2001) Novel dual "small" vesicle model of ATP- and noradrenaline-mediated sympathetic neuromuscular transmission. Auton Neurosci 87:16-36.
41. Stjarne L, Astrand P, Bao JX, Gonon F, Msghina M, and Stjarne E (1994) Spatiotemporal pattern of quantal release of ATP and noradrenaline from sympathetic nerves: Consequences for neuromuscular transmission. Adv Second Messenger Phosphoprotein Res 29:461-498.
42. Stjarne L, Lundberg JM, and Astrand P (1986) Neuropeptide Y a cotransmitter with noradrenaline and adenosine 5′-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience 18:151-166.
43. Stone TW, O'Kane EM, Nikbakht MR, and Ross FM (2000) Presynaptic P2 receptors? J Auton Nerv Syst 81:244-248.
44. Taylor P (2001) Anticholinesterase agents, in Goodman and Gilman's The Pharmacological Basis of Therapeutics (Hardman JG and Limbird L eds) pp 175-191, McGraw-Hill, New York.
45. Todorov LD, Bjur RA, and Westfall DP (1994a) Temporal dissociation of the release of the sympathetic cotransmitters ATP and noradrenaline. Clin Exp Pharmacol Physiol 21:931-932.
46. Todorov LD, Bjur RA, and Westfall DP (1994b) Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. J Pharmacol Exp Ther 268:985-989.
47. Todorov LD, Mihaylova-Todorova S, Craviso GL, Bjur RA, and Westfall DP (1996) Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea pig vas deferens. J Physiol 496:731-748.
48. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, and Westfall DP (1997) Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature (Lond) 387:76-79.
49. von Kugelgen I, Schoffel E, and Starke K (1989) Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 340:522-532.
50. von Kugelgen I and Starke K (1991) Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12:319-324.
51. Westfall DP, Dalziel HH, and Forsyth KM (1991) ATP as neurotransmitter, cotransmitter and neuromodulator, in Adenosine and Adenine Nucleotides as Regulators of Cellular Functions (Phillis J) pp 295-305, CRC Press, Inc., Boca Raton.
52. Westfall DP, Todorov LD, Mihaylova-Todorova S, and Bjur RA (1996a) Differences between the regulation of noradrenaline and ATP release. J Auton Pharmacol 16:393-395.
53. Westfall TD and Westfall DP (2001) Pharmacological techniques for the in vitro study of the vas deferens. J Pharmacol Toxicol Methods 45:109-122.
54. Westfall TD, Kennedy C, and Sneddon P (1996b) Enhancement of sympathetic purinergic neurotransmission in the guinea pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156. Br J Pharmacol 117:867-872.
55. Westfall TD, Kennedy C, and Sneddon P (1997) The effect of the novel ecto-ATPase inhibitor ARL 67156 on contractile responses to nerve stimulation and to drugs in the guinea pig urinary bladder. Eur J Pharmacol 329:169-174.
56. Westfall TD, Menzies JR, Liberman R, Waterston S, Ramphir N, Westfall DP, Sneddon P, and Kennedy C (2000a) Release of a soluble ATPase from the rabbit isolated vas deferens during nerve stimulation. Br J Pharmacol 131:909-914.
57. Westfall TD, Sarkar S, Ramphir N, Westfall DP, Sneddon P, and Kennedy C (2000b) Characterization of the ATPase released during sympathetic nerve stimulation of the guinea-pig isolated vas deferens. Br J Pharmacol 129:1684-1688.
58. Zimmermann H (1992) 5′-Nucleotidase molecular structure and functional aspects. Biochem J 285:345-365.
59. Zimmermann H (1999) Nucleotidase and CD39: Principle modulatory players in hemostasis and thrombosis. Nat Med 5:987-988.
60. Zimmermann H, Beaudoin AR, Bollen M, Goding JW, Guidotti G, Kirley TL, Robson SC, and Sano K (2000) Proposed nomenclature for two novel nucleotide hydrolyzing enzyme families expressed on the cell surface., in Ecto-ATPases and Related Ectonucleotidases (Vanduffel L and Lemmens R eds) pp 1-8, Shaker Publishing BV, Maastricht, The Netherlands.